Alex LopezJose Fernando Vera‐ChamorroAilim Margarita Carías DomínguezMónica Pinilla‐RoncancioRocío LópezGonzalo Andrés Montaño Rozo2026-03-222026-03-22202510.1155/cjgh/4633813https://doi.org/10.1155/cjgh/4633813https://andeanlibrary.org/handle/123456789/78479This is the first study to assess PPI response in Colombian pediatric EoE patients, demonstrating a response rate consistent with existing literature. Histologic evaluation was identified as the most reliable marker of treatment success, underscoring the critical role of histopathological follow-up in this disease.enMedicineInternal medicineEosinophilic esophagitisGastroenterologyDermatologyDiseaseResponse to Proton‐Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombiaarticle